miRNA | Reference | Sample Type | Evaluation Method | Cardiovascular condition | Expression Change to controls |
---|---|---|---|---|---|
miR-1-3p | [36] | Plasma | qPCR | Acute myocardial infarction | Increased |
[37] | Serum + urine | qPCR | Acute myocardial infarction | Increased | |
[38] | Plasma | NGS | Acute myocardial infarction | Increased | |
[39] | Plasma | qPCR | Acute myocardial infarction | Increased | |
[40] | Plasma | qPCR | Acute myocardial infarction | Increased | |
[41] | Plasma | qPCR | Acute myocardial infarction | Increased | |
[42] | FFPE myocardial tissue | qPCR | Sudden cardiac death | Increased | |
[43] | Plasma | NGS + qPCR | Failed myocardial reperfusion | Increased | |
[44] | PBMC | qPCR | Acute viral myocarditis | Increased | |
[45] | Plasma | qPCR | Hypertrophic cardiomyopathy | Increased | |
[46] | Cardiac tissue | qPCR | Hypertrophic cardiomyopathy | Decreased | |
[47] | Endomyocardial biopsies | qPCR + microarray | Dilated cardiomyopathies | Increased | |
[48] | Serum | qPCR | Transcoronary ablation of septal hypertrophy (TASH) | Increased | |
[49] | Myocardial tissue | NGS | Tetralogy of Fallot | Decreased | |
[50] | Plasma | qPCR | Takotsubo cardiomyopathy | Increased | |
[51] | PBMC | qPCR | Hypertensive heart disease | Increased | |
[52] | Plasma | qPCR | Non-ST elevation myocardial infarction (NSTEMI) | Increased | |
[53] | Plasma | qPCR | Acute coronary syndrome | Increased | |
[54] | Right arterial appendage biopsies + Plasma | qPCR | Atrial fibrillation | Increased | |
[55] | Myocardial tissue | qPCR + miRNA array | Atrial fibrillation | Increased | |
[56] | Myocardial tissue | qPCR | Heart failure | Decreased | |
[57] | Serum | qPCR | Heart failure | Decreased | |
[58] | Plasma | qPCR | Acute heart failure | Decreased | |
miR-17-5p | [59] | Plasma | qPCR | Acute coronary syndrome | Increased |
[60] | Plasma | dPCR | Coronary artery disease | Increased | |
[61] | Plasma | qPCR | Heart failure | Decreased | |
[62] | Plasma | qPCR | Hypertrophic cardiomyopathy | Increased | |
[63] | Whole blood | qPCR | Bicuspid aortic valve disorder | Decreased | |
miR-19a | [64] | Lung tissue | microarray | Pulmonary arterial hypertension | Increased |
[65] | Serum | qPCR | Acute coronary syndrome | Increased | |
[66] | Serum | microarray | Atherosclerosis | Increased | |
miR-29a-3p | [67] | Ascending aorta tissue | qPCR | Bicuspid aortic valve disorders | Decreased |
[68] | Serum | qPCR | Hypertrophic cardiomyopathy | Increased | |
[69] | Serum | qPCR | Hypertrophic cardiomyopathy | Increased | |
[62] | Plasma | qPCR | Hypertrophic cardiomyopathy | Increased | |
[70] | Plasma | NGS + FirePlex assay | Coronary heart disease | Increased | |
[71] | Plasma | qPCR | Coronary heart disease | Increased | |
[72] | Cardiac valve tissue | qPCR | Valvular heart disease | Decreased | |
[73] | Plasma | qPCR | Cardiac fibrosis | Increased | |
[74] | Plasma | qPCR | Left ventricular remodelling | Increased | |
[75] | Plasma | qPCR | Pulmonary arterial hypertension | Increased | |
miR-34a-5p | [76] | Plasma | qPCR | Chronic heart disease | Increased |
[77] | Whole blood | qPCR | Cardiac aging | Increased | |
[78] | Plasma | qPCR | Left ventricular (LV) remodelling | Increased | |
[79] | Plasma | qPCR | Left ventricular dysfunction | Increased | |
[80] | Plasma | qPCR | Heart failure | Increased | |
[81] | Serum | qPCR | Acute myocardial infarction | Increased | |
[82] | Serum | qPCR | Arterial fibrillation | Increased | |
miR-122-5p | [83] | Serum | qPCR | Coronary artery disease | Increased |
[84] | Plasma | microarray + qPCR | Acute coronary syndrome | Increased | |
[85] | Plasma | qPCR | Cardiogenic shock | Increased | |
[86] | Whole blood | qPCR | Cardiogenic shock | Increased | |
[87] | Plasma | qPCR | Ventricular fibrillation sudden cardiac arrest | Increased | |
[88] | Plasma | qPCR | Chronic systolic heart failure | Increased | |
[89] | Plasma | microarray | Aortic valve dysfunction | Decreased | |
[90] | Ascending aorta tissue + plasma | qPCR | Bicuspid aortic valve disease | Decreased | |
[91] | Myocardial tissue | NGS + qPCR | Arrythmogenic cardiomyopathy | Increased | |
[92] | Serum | qPCR | Acute myocardial infarction | Increased | |
[93] | Serum | microarray | Congestive heart failure | Increased | |
miR-130a | [59] | Plasma | qPCR | Acute coronary syndrome | Increased |
[94] | Plasma | qPCR | Peripartum cardiomyopathy | Increased | |
[95] | Whole blood | microarray | Pulmonary hypertension | Increased | |
[96] | Plasma | qPCR | Coronary heart disease | Decreased | |
[89] | Plasma | microarray | Aortic valve dysfunction | Increased | |
miR-199a-3p | [97] | Plasma | qPCR | Acute heart failure | Decreased |
[98] | Right arterial appendage biopsies | qPCR | Postoperative atrial fibrillation | Decreased | |
[99] | Plasma | qPCR | Coronary heart disease | Decreased | |
[100] | Right arterial appendage biopsies | qPCR | Coronary heart disease | Decreased | |
[101] | Plasma | qPCR | Stable coronary artery disease | Decreased | |
[102] | Plasma | qPCR | Peripheral arterial disease | Decreased | |
[103] | Plasma | microarray + qPCR | Atrial fibrillation in HFrEF patients | Increased | |
[104] | Plasma | NGS | Acute myocardial infarction | Increased | |
miR-378 | [105] | Plasma | qPCR | Coronary heart disease | Decreased |
[106] | Whole blood | microarray + qPCR | Coronary artery disease | Decreased | |
miR-423 | [107] | Plasma | qPCR | Acute myocardial infarction | Increased |
[108] | Plasma | qPCR | Dilated cardiomyopathy | Increased | |
[109] | Plasma | microarray | Heart failure | Increased | |
[58] | Plasma | qPCR | Acute heart failure | Decreased | |
[110] | Plasma | qPCR | Acute heart failure | Increased | |
[111] | Serum | qPCR | Coronary artery disease | Decreased | |
[38] | Plasma | NGS | Acute myocardial infarction | Increased | |
[112] | Plasma | qPCR | Acute myocardial infarction | Increased | |
[113] | Plasma | qPCR | Cardiogenic shock | Increased | |
[114] | Plasma | qPCR | Left ventricular remodelling | Increased | |
[115] | Serum | qPCR | Left ventricular remodelling | Increased | |
[116] | Whole blood | microarray + qPCR | Transposition of the great arteries | Increased | |
[117] | Serum | qPCR | Heart failure | Increased | |
[80] | Plasma | qPCR | Heart failure | Increased | |
miR-499 | [38] | Plasma | NGS | Acute myocardial infarction | Increased |
[41] | Plasma | qPCR | Acute myocardial infarction | Increased | |
[118] | Plasma | qPCR | Acute myocardial infarction | Increased | |
[119] | Whole blood | qPCR | Acute myocardial infarction | Increased | |
[120] | Serum | dPCR+qPCR | Stable coronary artery disease | Increased | |
[40] | Plasma | qPCR | Acute coronary syndrome | Increased | |
[121] | Plasma | qPCR | Acute coronary syndrome | Increased | |
[115] | Serum | qPCR | ST-segment-elevation myocardial infarction (STEMI) | Increased | |
[52] | Plasma | qPCR | Non-ST elevation myocardial infarction (NSTEMI) | Increased | |
[122] | Endomyocardial biopsies | qPCR | Dilated cardiomyopathy | Increased | |
[123] | PBMC | qPCR | Heart failure with preserved ejection fraction (HFpEF) | Increased | |
[42] | FFPE myocardial tissue | qPCR | Sudden cardiac death | Increased | |
[83] | Serum | qPCR | Unstable coronary artery disease | Increased | |
miR-885-5p | Â | Â | Â | No relevant associations | Â |
miR-1273 g-3p |  |  |  | No relevant associations | – |
miR-4638-3p |  |  |  | No relevant associations | – |